Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06335355
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-28
First Post:
2024-03-21
Brief Title:
A Phase IIIII Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients
Sponsor:
Shanghai Shengdi Pharmaceutical Co Ltd
Organization:
Shanghai Shengdi Pharmaceutical Co Ltd
Organization Data
Organization:
Shanghai Shengdi Pharmaceutical Co Ltd
Class:
INDUSTRY
Study ID:
SHR-1316-307
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Shengdi Pharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None